1h Free Analyst Time
The publisher has been monitoring the sequencing reagents market and it is poised to grow by $ 4.09 bn during 2022-2026, progressing at a CAGR of 12.32% during the forecast period. This report on the sequencing reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing affordability of DNA sequencing, growing demand for early diagnosis of genetic disorders, and expanding applications of DNA sequencing.
The sequencing reagents market analysis includes the technology segment and geographic landscape.
The publisher's sequencing reagents market is segmented as below:
By Technology
- Next-generation sequencing
- Sanger sequencing
- Third generation sequencing
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advances in next generation sequencing techniques as one of the prime reasons driving the sequencing reagents market growth during the next few years. Also, development of sophisticated bioinformatics tools for next generation sequencing and automation of DNA sequencing will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
This report on sequencing reagents market covers the following areas:
- Sequencing reagents market sizing
- Sequencing reagents market forecast
- Sequencing reagents market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sequencing reagents market vendors that include Agilent Technologies Inc., BGI Group, BioChain Institute Inc., F. Hoffmann La Roche Ltd., Fluidigm Corp., FroggaBio Inc., Illumina Inc., LGC Biosearch Technologies, Meridian Bioscience Inc, New England Biolabs Inc., Oxford Nanopore Technologies plc, PerkinElmer Inc., QIAGEN NV, Thermo Fisher Scientific Inc., Tecan Group Ltd., Trilink Biotechnologies, Merck KGaA, Pacific Biosciences of California Inc., and Takara Bio Inc. Also, the sequencing reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Technology
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- BGI Group
- BioChain Institute Inc.
- F. Hoffmann La Roche Ltd.
- Fluidigm Corp.
- FroggaBio Inc.
- Illumina Inc.
- LGC Biosearch Technologies
- Meridian Bioscience Inc
- New England Biolabs Inc.
- Oxford Nanopore Technologies plc
- PerkinElmer Inc.
- QIAGEN NV
- Thermo Fisher Scientific Inc.
- Tecan Group Ltd.
- Trilink Biotechnologies
- Merck KGaA
- Pacific Biosciences of California Inc.
- Takara Bio Inc.
